Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF JANUARY 26, 2022 SAM #7361
MODIFICATION

65 -- Notice of intent to solicit and negotiate a non-competitive modification for PCV 20 vaccine (Prevnar20)

Notice Date
1/24/2022 7:10:24 AM
 
Notice Type
Justification
 
NAICS
325412 — Pharmaceutical Preparation Manufacturing
 
Contracting Office
CDC OFFICE OF ACQUISITION SERVICES ATLANTA GA 30333 USA
 
ZIP Code
30333
 
Solicitation Number
75D30121D1135500004
 
Archive Date
02/23/2022
 
Point of Contact
Joshua Houston, Pellumbeshe Hoxhaj
 
E-Mail Address
pkf5@cdc.gov, kfx2@cdc.gov
(pkf5@cdc.gov, kfx2@cdc.gov)
 
Award Number
75D30121D11355
 
Award Date
01/21/2022
 
Description
CDC awarded modification no. 00004 to contract no. 75D30121D11355 to Pfizer Inc. (�Pfizer�), 235 E 42nd St, New York, NY 10017-5703, on January 21, 2022, in the amount of $52,107,000.00. This notices makes available a justification and approval for other than full and open competition (JOFOC) that applies to this contract. This contract was awarded under the authority of FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. This modification was made to a contract part of CDC�s 2021 Vaccines For Adults (VFA) indefinite-delivery indefinite-quantity contracts. This contract provides for the purchase of standard commercial adult vaccines for the National Center for Immunization and Respiratory Diseases� (NCIRD) immunization awardees (the fifty state health departments, several large city program and current and former U.S. Territories) to support immunization programs as provided under Section 317(j) of the Public Health Service Act and Section 13631of the Omnibus Budget Reconciliation Act of 1993. The purpose of this modification is to add the Pneumococcal 20-valent Conjugate Vaccine (PCV 20) PREVNAR 20� to the contract following the Advisory Committee on Immunization Practices (ACIP) approval and CDC recommendation in October 2021. Pfizer was determined to be the only responsible source because Pfizer is the only manufacturer with an FDA-approved license for PCV 20 at this time. The attached JOFOC is being made available within 14 days of the contract award in accordance with FAR 6.305(a) and will remain active for 30 days in accordance with FAR 6.305(d)(3).
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/467c86157cbb4ad78b3e47c3856eeee8/view)
 
Place of Performance
Address: USA
Country: USA
 
Record
SN06222232-F 20220126/220125201428 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.